Drug Price Disclosure Mandate Relies On CMS Law; Enforcement Is On Companies

By John Wilkerson / October 15, 2018 at 7:27 PM
HHS is relying on Medicare and Medicaid law to require brands to post drug prices in TV ads and is counting on drug companies to sue each other when they don’t, HHS officials said Monday (Oct. 15). HHS Secretary Alex Azar said the administration is proposing that Wholesale Acquisition Costs, which are list prices, be listed in ads for drugs that Medicare and Medicaid buys. The Federal Trade Commission and FDA share jurisdiction over prescription drug advertising, but the two...


Not a subscriber? Sign up for 30 days free access to exclusive, detailed reporting on drug pricing reforms, Medicaid policy, FDA news and much more.